Key Takeaways
- Japanese knotweed (Polygonum cuspidatum) adalah sumber komersial utama trans-resveratrol, yang mengandung konsentrasi jauh lebih tinggi dibandingkan anggur atau beri
- Tanaman ini mengandung beberapa senyawa bioaktif — resveratrol, polydatin, emodin, dan quercetin — masing-masing dengan sifat yang didukung oleh penelitian yang berbeda
- Bukti anti-inflamasi adalah yang terkuat, didukung oleh meta-analisis dan dua uji klinis khusus knotweed yang menunjukkan pengurangan signifikan pada penanda inflamasi
- Keamanan umumnya baik pada dosis standar, tetapi interaksi dengan pengencer darah dan obat diabetes memerlukan kehati-hatian
- Di Jepang, akar itadori diklasifikasikan sebagai bahan farmasi dan tidak dapat dijual dalam suplemen makanan — sebuah perbedaan regulasi yang biasanya tidak disebutkan dalam panduan berbahasa Inggris.
- Polydatin, stilbenoid paling melimpah dalam knotweed, mungkin menawarkan penyerapan yang lebih baik dibandingkan resveratrol bebas menurut tinjauan penting dengan lebih dari 300 kutipan
If you have been researching resveratrol supplements, you may have noticed something surprising: the most common source is not grapes or red wine, but a plant called Japanese knotweed. Known in Japan as "itadori" — a word that literally translates to "pain remover" — this plant has been used in traditional Asian medicine for centuries, long before modern science identified the compounds inside it.
Yet most guides on Japanese knotweed supplements barely scratch the surface. They focus almost exclusively on resveratrol while overlooking the other bioactive compounds that make knotweed extracts unique, like polydatin and emodin. And almost none draw on the extensive Japanese-language research that provides a completely different perspective on this plant's health potential.
This guide examines what the clinical evidence actually shows about Japanese knotweed supplements — the strong findings, the mixed results, and the important safety considerations. We also explore what Japanese researchers have discovered that most English-language sources miss entirely, including a surprising regulatory detail about how Japan treats this plant compared to the rest of the world.
What Is Japanese Knotweed?
Botanical Background
Japanese knotweed (Polygonum cuspidatum, also classified as Reynoutria japonica or Fallopia japonica) is a perennial plant native to East Asia, growing naturally across Japan, China, and Korea. The plant features tall, bamboo-like stems and heart-shaped leaves, and its root (rhizome) is the primary part used in both traditional medicine and modern supplements.
Outside Asia, Japanese knotweed has earned a very different reputation. It is listed among the world's 100 most invasive species, capable of growing through concrete and asphalt. Yet this same resilience hints at the plant's remarkable biochemistry — its roots contain over 67 identified compounds spanning multiple classes, including stilbenoids, anthraquinones, flavonoids, and proanthocyanidins [1].
Traditional Medicine History
Japanese knotweed has a centuries-long history in both Japanese and Chinese traditional medicine. In China, the root is known as "hu zhang" (虎杖, meaning "tiger staff") and has been used to clear heat, resolve toxins, and promote circulation. It appears in the Chinese Pharmacopoeia as a recognized medicinal ingredient.
In Japanese folk medicine, the plant goes by "itadori" (イタドリ), a name derived from "痛取り" — literally "pain remover." This etymology reflects its traditional use as a mild analgesic and anti-inflammatory remedy. Japanese practitioners also used itadori root for constipation, bladder inflammation, kidney stones, and menstrual irregularities [21].
This traditional use for pain and inflammation has proven remarkably prescient. Modern research has confirmed that the plant's primary compound — resveratrol — works through several of the same anti-inflammatory pathways that traditional practitioners observed empirically.
Key Bioactive Compounds in Japanese Knotweed
Unlike isolated resveratrol supplements, whole Japanese knotweed extracts deliver a multi-compound profile. Each compound contributes distinct properties.
Resveratrol (trans-Resveratrol)
Resveratrol is the stilbenoid that put Japanese knotweed on the supplement map. It is a polyphenol with extensively studied anti-inflammatory, antioxidant, cardioprotective, and neuroprotective potential [1]. Japanese knotweed root is the richest natural source of trans-resveratrol, far exceeding the trace amounts found in grape skins, red wine, or berries. This is why the vast majority of commercial resveratrol supplements use knotweed as their source material.
Polydatin (Piceid)
Polydatin is actually the most abundant stilbenoid in Japanese knotweed — more prevalent than free resveratrol itself. It is a resveratrol glucoside, meaning it has a glucose molecule attached. A landmark review with over 300 citations documented polydatin's cardioprotective, hepatoprotective, anti-inflammatory, and antioxidant effects [9].
What makes polydatin particularly interesting is its potential bioavailability advantage. Because of its glucoside structure, polydatin can be absorbed via sodium-dependent glucose transporters in the intestine — a form of active transport that free resveratrol cannot use [10]. This may help explain why whole knotweed extracts sometimes show effects that isolated resveratrol at similar doses does not.
Emodin
Emodin is an anthraquinone compound with demonstrated laxative, anti-inflammatory, antimicrobial, and anticancer properties in preclinical studies. A pharmacokinetics study showed that emodin from oral knotweed extract distributes to liver, lung, and kidney tissues in animal models [2]. While emodin adds to the multi-compound benefit profile, it also contributes to potential side effects — particularly the gastrointestinal symptoms associated with higher knotweed doses.
Other Compounds
Japanese knotweed also contains quercetin (a flavonoid with anti-inflammatory and antihistamine properties), physcion, catechins, and proanthocyanidins. Two clinical trials using whole knotweed extract (PCE) demonstrated anti-inflammatory effects that isolated resveratrol at equivalent doses did not consistently replicate — suggesting these additional compounds may work synergistically [13][14].
Evidence-Based Benefits of Japanese Knotweed
An important note before diving in: most clinical evidence comes from resveratrol studies using various sources, not knotweed specifically. Only two small clinical trials have used actual Japanese knotweed extract (PCE). We note the distinction for each benefit area below.
Anti-Inflammatory Properties — Strong Evidence
This is the best-supported benefit area for Japanese knotweed. Two systematic reviews with meta-analyses confirm that resveratrol supplementation significantly reduces key inflammatory markers:
- A meta-analysis of randomized controlled trials found significant reductions in C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α) [3]
- A separate meta-analysis confirmed significant reductions in inflammatory cytokines including IL-6 and TNF-α [4]
More importantly, two clinical trials specifically used knotweed extract:
- In a trial with 20 basketball players, 200 mg of knotweed extract containing 40 mg trans-resveratrol significantly reduced TNF-α and IL-6 plasma levels after 6 weeks compared to placebo [13]
- In healthy subjects, 40 mg resveratrol from knotweed extract suppressed reactive oxygen species and inflammatory markers in immune cells over 6 weeks [14]
A third trial in Gulf War Illness patients found promising anti-inflammatory effects using resveratrol derived specifically from P. cuspidatum [15].
Cardiovascular Health — Moderate Evidence
A systematic review and meta-analysis of randomized clinical trials found that resveratrol supplementation significantly reduced systolic blood pressure, particularly at doses of 300 mg/day or higher and in studies lasting longer than 12 weeks. The effect was more pronounced in individuals with existing cardiometabolic conditions [5].
However, no knotweed-specific cardiovascular trials have been conducted. The cardiovascular evidence comes entirely from resveratrol trials using various sources.
Antioxidant Activity — Moderate Evidence
Two meta-analyses examined resveratrol's effects on oxidative stress markers. Both found a significant therapeutic effect on glutathione peroxidase (GPx) levels, though results were inconsistent for other markers like SOD, TAC, and MDA [6][7].
The knotweed-specific trial in healthy subjects demonstrated ROS suppression in immune cells with 40 mg resveratrol from PCE [14]. While promising, the evidence for broad antioxidant benefits remains mixed.
Brain Health and Neuroprotection — Emerging Evidence
No knotweed-specific neuroprotection trials exist. One clinical trial in Alzheimer's disease patients used high-dose resveratrol (500-2,000 mg/day for 52 weeks) and found decreased amyloid-beta levels in cerebrospinal fluid and plasma. The treatment was well-tolerated, though no other biomarker changes were observed.
Preclinical studies from a comprehensive knotweed review show that resveratrol protected neuronal cells at laboratory concentrations, and physcion glucoside (another knotweed compound) improved maze performance in animal models of dementia [1]. These findings are preliminary and require human clinical validation.
Immune Support — Emerging Evidence
A meta-analysis of 47 randomized controlled trials found that dietary polyphenols, including resveratrol, significantly improved inflammatory markers in rheumatoid arthritis patients, supporting immune-modulating potential [8].
Preclinical data shows resveratrol has antiviral activity and emodin has antimicrobial properties in laboratory settings [1]. However, no clinical trials have tested these effects in humans.
Liver Health — Mixed Evidence
This area requires careful handling. A mechanistic review documents hepatoprotective properties of knotweed compounds through anti-inflammatory, antioxidant, and bile acid regulation pathways [16].
However, a clinical trial using high-dose resveratrol (1,500 mg/day for 6 months) in patients with non-alcoholic fatty liver disease found no improvement in liver inflammation or fibrosis, and one serious adverse event (fever and bicytopenia) occurred in the treatment group [11]. Additionally, Chinese regulatory authorities have documented nearly 10,000 adverse event reports from knotweed-based preparations, with liver-related concerns being a primary issue. We recommend approaching liver health claims with caution.
Japanese Knotweed vs Other Resveratrol Sources
One of the most common questions is how Japanese knotweed compares to other resveratrol sources. Here is a side-by-side comparison:
| Feature | Japanese Knotweed | Grape Extract | Red Wine | Berries |
|---|---|---|---|---|
| Resveratrol concentration | Very high — primary commercial source worldwide | Low — trace amounts in skins and seeds | Very low — 1-2 mg per glass | Minimal |
| Additional compounds | Emodin, polydatin, quercetin, physcion | Proanthocyanidins primarily | Various polyphenols | Various antioxidants |
| Polydatin content | Most abundant stilbenoid — may improve absorption | Minimal | Minimal | Negligible |
| Standardization | Easy to standardize for trans-resveratrol % | Variable by grape variety | Not standardized | Not standardized |
| Cost | Lower — abundant plant source | Higher — agricultural product | Not practical as supplement | Not practical as supplement |
| Safety consideration | Emodin may cause GI effects at higher doses | Fewer additional compound concerns | Alcohol content | Generally well-tolerated |
| Bioavailability | Low (<5% for free resveratrol), polydatin may help | Similarly low | Low | Low |
The key advantage of Japanese knotweed is not just its resveratrol concentration but the multi-compound profile. Polydatin, the most abundant stilbenoid, may have superior absorption due to glucose transporter-mediated uptake [9] — a property that grape-derived resveratrol lacks. Two clinical trials suggest whole knotweed extract produces effects beyond what isolated resveratrol achieves at equivalent doses [13][14].
How to Choose a Japanese Knotweed Supplement
Supplement Forms
Japanese knotweed supplements come in several forms:
- Capsules: The most common format. Easy to dose accurately. Look for standardized trans-resveratrol content.
- Powder: Often less expensive. Can be mixed into drinks but may have a bitter taste from emodin.
- Liquid extract/tincture: May offer faster absorption. Harder to standardize for specific compound percentages.
What to Look for on Labels
When evaluating Japanese knotweed supplements, check for:
- Source identification: Polygonum cuspidatum or Reynoutria japonica listed as the source ingredient
- Standardized trans-resveratrol content: A specific percentage (commonly 50% or 98%) rather than vague "knotweed extract"
- Whether it is whole extract or isolated resveratrol: Whole extracts contain the full compound profile; isolated resveratrol supplements may use knotweed as a starting material but strip away other compounds
- Third-party testing: Independent verification of potency and purity
Quality Indicators
Look for GMP (Good Manufacturing Practice) certification, third-party testing seals (USP, NSF, or ConsumerLab), and transparency about the extraction process. Avoid supplements that list proprietary blends without disclosing the actual resveratrol content in milligrams.
Dosage and How to Take
There is no universally agreed-upon dose for Japanese knotweed supplements. Clinical trial dosages provide the best guidance:
- Knotweed-specific trials: 200 mg knotweed extract containing 40 mg trans-resveratrol, taken daily for 6 weeks [13]
- Blood pressure benefits: Meta-analysis data suggests doses of 300 mg/day or higher of resveratrol for cardiovascular effects [5]
- General resveratrol trials: Dosages range from 20 mg to 2,000 mg/day, though higher doses carry increased side effect risk
- UK regulatory guidance: 150 mg/day resveratrol for adults
Taking knotweed supplements with food may improve absorption. Start with a lower dose and increase gradually to assess tolerance, particularly because of emodin's potential gastrointestinal effects.
How Long Until Results?
Based on clinical trial timelines, expect 4-12 weeks before noticing measurable effects. The knotweed-specific anti-inflammatory trials ran for 6 weeks. Blood pressure studies typically need 12 or more weeks. A 12-week pilot study in older adults confirmed that resveratrol supplementation was well-tolerated over this timeframe [12].
Safety Considerations
Common Side Effects
The most commonly reported side effects are gastrointestinal symptoms: abdominal discomfort, diarrhea, and nausea. These are linked primarily to the resveratrol and emodin content. A 12-week placebo-controlled pilot study in older adults found no significant difference in adverse events between resveratrol and placebo groups at moderate doses [12].
At high doses, the picture changes. A trial using 1,500 mg/day resveratrol for 6 months reported one serious adverse event (fever and bicytopenia) [11], and Chinese regulatory data documents nearly 10,000 adverse event reports from knotweed-based preparations.
Drug Interactions
Several interactions warrant caution:
- Blood thinners (warfarin, aspirin): Resveratrol has anticoagulant and antiplatelet properties that may increase bleeding risk. This is one of the most important interactions to be aware of [23].
- Diabetes medications: A meta-analysis found resveratrol affects blood lipid and glucose control — combining it with diabetes drugs could increase hypoglycemia risk [19].
- Antihypertensives: Since resveratrol can lower blood pressure, additive effects are possible with blood pressure medications.
- CYP450-metabolized drugs: Resveratrol is metabolized via CYP enzymes, creating theoretical interactions with other drugs sharing these pathways.
- Estrogen-sensitive conditions: Resveratrol has weak estrogenic activity, which may be a concern for hormone-sensitive conditions.
Who Should Avoid Japanese Knotweed Supplements
- Pregnant individuals: Traditional pharmacopeias report potential abortifacient effects, and no clinical safety data exists [23]
- Nursing individuals: Insufficient safety data — best to avoid
- People with liver disease: Caution based on adverse event data from regulatory authorities
- Pre-surgery: Discontinue at least 2 weeks before any scheduled surgery due to anticoagulant effects
- Children: Insufficient data; medical supervision required
Realistic Expectations
Japanese knotweed supplements are not a cure for any condition. The strongest evidence supports anti-inflammatory benefits, but even this is based on small trials. Two well-designed clinical trials found no benefit for type 2 diabetes [17] or metabolic syndrome [18] — reminders that promising preclinical results do not always translate to clinical outcomes. Consider Japanese knotweed supplements as one part of a broader approach to wellness, not a standalone solution.
From Itadori to Clinical Trials: What Japanese Research Reveals
Japanese knotweed has a fascinating dual identity: an invasive pest feared by homeowners across Europe and North America, yet a valued medicinal plant in its native Japan. Exploring what Japanese researchers know about this plant reveals insights that English-language guides consistently miss.
The Pain Remover: Japan's Centuries of Itadori Use
The Japanese name "itadori" derives from "痛取り" — literally "pain remover." While English sources typically cite Chinese traditional medicine (TCM) as the primary historical context for knotweed, Japanese folk medicine developed its own distinct applications. Japanese practitioners used itadori for constipation, bladder inflammation, kidney stones, and as a mild analgesic — a gentler, more everyday health application compared to TCM's emphasis on clearing "heat and toxins" [21].
Why this matters: The Japanese traditional use for pain aligns remarkably well with the modern anti-inflammatory evidence, suggesting empirical observation preceded scientific validation by centuries.
Why Japan Regulates Knotweed Differently
Here is something no English-language guide on Japanese knotweed supplements seems to mention: in Japan, itadori root is classified on the Ministry of Health, Labour and Welfare (MHLW) "exclusively pharmaceutical ingredient" list. This means it cannot legally be sold in food products or dietary supplements in Japan [22].
This is a striking regulatory contrast. In the United States, Europe, and most other markets, Japanese knotweed extract is freely sold as a dietary supplement. In Japan — the plant's namesake country — it is treated as a pharmaceutical ingredient requiring stricter oversight.
Why this matters: Japan's conservative classification reflects a regulatory philosophy that treats potent botanicals with pharmaceutical-level caution, particularly given the emodin content and potential liver effects at higher doses.
The Longevity Connection
Japanese researchers bring a distinctive lens to resveratrol research. While English-language studies tend to focus on specific disease endpoints (cardiovascular, inflammatory), Japanese researchers at institutions like those publishing in J-STAGE explicitly study resveratrol's "健康長寿効果" (healthy longevity effects), emphasizing SIRT1 activation and caloric restriction mimicry — the biological mechanisms thought to underlie lifespan extension [25][26].
Why this matters: This anti-aging research angle is largely absent from Western literature on knotweed, offering a broader perspective on the compound's potential beyond treating specific conditions.
Whole-Plant Thinking vs Isolated Compounds
A doctoral thesis from Okayama Prefectural University investigated polyphenol-rich materials from itadori, identifying specific resveratrol derivatives and chlorogenic acid with alpha-glucosidase inhibitory activity — suggesting potential as a functional food ingredient for blood sugar management [20]. This exemplifies a broader Japanese research tendency: studying the whole plant's compound interactions rather than isolating single molecules.
Why this matters: Japanese research suggests that knotweed's benefits may come from compound synergy, not just resveratrol alone — aligning with the clinical trial data showing whole knotweed extract outperforming isolated resveratrol at equivalent doses.
Our Recommendation
My Care Itadori (マイケア イタドリ)
Why We Selected This: My Care Itadori is a Japanese knotweed supplement from a Japanese manufacturer that leverages Japan's deep understanding of the itadori plant. The formulation draws on the traditional Japanese approach of utilizing the whole-plant extract rather than isolated resveratrol alone, delivering the multi-compound profile that clinical research suggests may offer advantages over single-compound supplements.
Conclusion
Japanese knotweed supplements offer one of the richest natural sources of resveratrol, backed by a multi-compound profile that isolated resveratrol supplements cannot match. The anti-inflammatory evidence is genuinely strong, supported by both meta-analyses and knotweed-specific clinical trials. Cardiovascular and antioxidant benefits show moderate evidence, while neuroprotective and immune-supportive properties remain in early research stages.
What stands out most is the gap between how the world views this plant and how Japan treats it. In the West, it is sold freely as a dietary supplement. In Japan, it is classified as a pharmaceutical ingredient — a regulatory distinction that reflects the respect Japanese authorities have for the plant's potency.
If you are considering a Japanese knotweed supplement, look for standardized extracts with verified trans-resveratrol content, start with moderate doses, and be transparent with your healthcare provider about any medications you take. The evidence is promising, and the centuries of traditional use are compelling — but as with any supplement, the most honest recommendation is to approach it as one tool among many in a broader wellness strategy.
This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new health regimen, especially if you have existing health conditions or take medications. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions
- Kemajuan dalam aktivitas farmakologis Polygonum cuspidatum - Sebuah tinjauan
- Farmakokinetik dan distribusi jaringan resveratrol, emodin, dan metabolitnya setelah konsumsi Polygonum cuspidatum pada tikus
- Efek suplementasi resveratrol pada penanda inflamasi: tinjauan sistematis dan meta-analisis dari RCTs
- Efek resveratrol pada sitokin inflamasi: Meta-analisis uji coba terkontrol secara acak
- Efek resveratrol pada tekanan darah: Tinjauan sistematis dan meta-analisis
- Efek terapeutik suplementasi resveratrol terhadap stres oksidatif: tinjauan sistematis dan meta-analisis dari RCTs
- Efek resveratrol pada penanda stres oksidatif: tinjauan sistematis dan meta-analisis
- Efikasi dan keamanan polifenol dalam diet pada rheumatoid arthritis: Tinjauan sistematis dan meta-analisis dari 47 RCT
- Polydatin: tinjauan farmakologi dan farmakokinetik
- Apakah Mungkin Meningkatkan Bioavailabilitas Resveratrol dan Polidatin
- Uji klinis acak terkontrol plasebo: pengobatan resveratrol dosis tinggi untuk NAFLD
- Keamanan dan hasil metabolik suplementasi resveratrol pada orang dewasa lanjut usia: studi percontohan terkontrol plasebo selama 12 minggu
- Ekstrak Knotweed RCT pada pemain bola basket
- Ekstrak Knotweed RCT pada subjek sehat: Penekanan ROS dan penanda inflamasi
- Uji coba silang pseudo-acak terkontrol plasebo terhadap agen botani untuk Penyakit Perang Teluk: resveratrol (Polygonum cuspidatum)
- Efek pelindung dari konstituen bioaktif Polygonum cuspidatum terhadap cedera hati kolestatik
- Enam bulan suplementasi resveratrol tidak memberikan efek yang terukur pada pasien diabetes tipe 2
- Tidak ada efek menguntungkan dari resveratrol pada sindrom metabolik: uji klinis acak terkontrol plasebo
- Suplemen Resveratrol pada pengendalian lipid darah dan glukosa darah pada T2D: tinjauan sistematis dan meta-analisis
